2017年无锡市水痘病例疾病负担分析
|
摘要
目的分析无锡市2017年水痘病例疾病负担情况,为行政部门制定免疫策略提供依据。方法抽取2017年中国疾病预防控制信息系统报告的无锡市水痘病例528例,通过对病例进行调查,获取疾病负担情况。结果门诊病例人均经济负担549.19元,住院病例人均经济负担3 925.59元,负担中占比最高的均为医药费,城镇居民的经济负担高于农村居民;病例的人均无形经济损失668.37元,其中城镇居民高于农村居民,住院病例高于门诊病例。结论无锡市水痘病例疾病负担较重,建议通过疫苗免疫加强水痘疫情的防控。
Objective The aim of this study was to analyze the disease burden of varicella cases in Wuxi in 2017, in order to provide basis for administrative departments to formulate immunization strategies. Methods A stratified random sampling method was adopted to select 528 cases reported in CDC disease information system in Wuxi city in 2017. Cases were investigated to access disease burden. Results The average economic burden of outpatient cases was 549.19 yuan, and the average economic burden of hospitalized patients was 3925.59 yuan. The economic burden of urban residents was higher than that of rural residents, and the highest proportion was medical expense. The per capita intangible economic loss of the cases was 668.37 yuan, of which the urban residents were higher than the rural residents, and the hospitalized cases were higher than the outpatient cases. Conclusion The disease burden of varicella cases in Wuxi was heavy. It is suggested that vaccination should be strengthened to prevent and control varicella.
Objective The aim of this study was to analyze the disease burden of varicella cases in Wuxi in 2017, in order to provide basis for administrative departments to formulate immunization strategies. Methods A stratified random sampling method was adopted to select 528 cases reported in CDC disease information system in Wuxi city in 2017. Cases were investigated to access disease burden. Results The average economic burden of outpatient cases was 549.19 yuan, and the average economic burden of hospitalized patients was 3925.59 yuan. The economic burden of urban residents was higher than that of rural residents, and the highest proportion was medical expense. The per capita intangible economic loss of the cases was 668.37 yuan, of which the urban residents were higher than the rural residents, and the hospitalized cases were higher than the outpatient cases. Conclusion The disease burden of varicella cases in Wuxi was heavy. It is suggested that vaccination should be strengthened to prevent and control varicella.
引文
[1]无锡市统计局.无锡市统计年鉴2017[M].北京:中国统计出版社,2017.
[2]刘刚,刘卫民,潘彩珠,等.广东省深圳市水痘病例疾病经济负担调查分析[J].医学动物防制,2017,10(10):1054-1056.
[3]崔伟红,冯国跃,郝凤,等.烟台市2013-2014年水痘患者经济负担及影响因素分析[J].中国预防医学杂志,2017,2(2):120-123.
[4]孙冬,张梅光,孙龙,等.2014-2015年开封市水痘患者经济负担及影响因素分析[J].河南预防医学杂志,2017,28(10):730-733.
[5]张晓曙,王小玲,李慧,等.甘肃省14岁以下儿童水痘住院病例经济负担调查[J].中国热带医学,2012,12(1):42-45.
[6] Guillen JM, Gil-Prieto R, Alvaro A, et al. Burden of adult varicella hospitalizations in Spain(2001-2007)[J]. Human vaccines, 2010, 6(8):659-663.
[7] Marin M, Meissner HC, Seward JF. Varicella prevention in the United States:a review of successes and challenges[J]. Pediatrics, 2008,122(3):e744-e751.
[8] Scuffham PA, Lowin AV, Burgess MA. The cost-effectiveness of varicella vaccine programs for Australia[J]. Vaccine, 1999, 18(5/6):407-415.
[9]殷大鹏.WHO水痘和带状疱疹立场文件解读[J].首都公共卫生,2018,12(3):120-121.
[10]李娜,张双凤.我国第二类疫苗接种现状及其影响因素研究进展[J].中国预防医学杂志,2018,19(7):548-552.
[11] American Academy of Pediatrics Committee on Infectious Diseases.Prevention of varicella:recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule[J]. Pediatrics, 2007, 120(1):221-231.
[12] Sosa LE, Hadler JL. Epidemiology of varicella in Connecticut, 2001-2005[J]. Journal of Infectious Diseases, 2008, 197(2):S90-S93.
[13]苏炜.突破性水痘临床特征分析[J].中国全科医学,2011,14(35):4111-4113.
[14]许翠平,陈春芝,李娟.北京市某区水痘疫苗2剂次接种方案实施效果评价及水痘防控策略探讨[J].中华实验和临床感染病杂志(电子版),2017,8(4):388-391.
[2]刘刚,刘卫民,潘彩珠,等.广东省深圳市水痘病例疾病经济负担调查分析[J].医学动物防制,2017,10(10):1054-1056.
[3]崔伟红,冯国跃,郝凤,等.烟台市2013-2014年水痘患者经济负担及影响因素分析[J].中国预防医学杂志,2017,2(2):120-123.
[4]孙冬,张梅光,孙龙,等.2014-2015年开封市水痘患者经济负担及影响因素分析[J].河南预防医学杂志,2017,28(10):730-733.
[5]张晓曙,王小玲,李慧,等.甘肃省14岁以下儿童水痘住院病例经济负担调查[J].中国热带医学,2012,12(1):42-45.
[6] Guillen JM, Gil-Prieto R, Alvaro A, et al. Burden of adult varicella hospitalizations in Spain(2001-2007)[J]. Human vaccines, 2010, 6(8):659-663.
[7] Marin M, Meissner HC, Seward JF. Varicella prevention in the United States:a review of successes and challenges[J]. Pediatrics, 2008,122(3):e744-e751.
[8] Scuffham PA, Lowin AV, Burgess MA. The cost-effectiveness of varicella vaccine programs for Australia[J]. Vaccine, 1999, 18(5/6):407-415.
[9]殷大鹏.WHO水痘和带状疱疹立场文件解读[J].首都公共卫生,2018,12(3):120-121.
[10]李娜,张双凤.我国第二类疫苗接种现状及其影响因素研究进展[J].中国预防医学杂志,2018,19(7):548-552.
[11] American Academy of Pediatrics Committee on Infectious Diseases.Prevention of varicella:recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule[J]. Pediatrics, 2007, 120(1):221-231.
[12] Sosa LE, Hadler JL. Epidemiology of varicella in Connecticut, 2001-2005[J]. Journal of Infectious Diseases, 2008, 197(2):S90-S93.
[13]苏炜.突破性水痘临床特征分析[J].中国全科医学,2011,14(35):4111-4113.
[14]许翠平,陈春芝,李娟.北京市某区水痘疫苗2剂次接种方案实施效果评价及水痘防控策略探讨[J].中华实验和临床感染病杂志(电子版),2017,8(4):388-391.